Variation in Maximal Doses of Vasopressors Used for Treatment of Shock in Intensive Care Units in Alberta Canada: A Retrospective Cohort Study
In Alberta CA, the maximum combined vasopressor dose for patients with shock varied between ICUs after adjustment for severity of illness. Some survival occurred even with high maximal doses. Further work is needed to understand the best approach to determining maximum doses for individual patients at high risk of death.
Authors
- Ruxandra Pinto
- Martin Chapman (ORCID: https://orcid.org/0000-0002-0882-9951)
- Allan J. Walkey (ORCID: https://orcid.org/0000-0003-4685-6894)
- Bijan Teja (ORCID: https://orcid.org/0000-0002-4978-6353)
- Henry T. Stelfox (ORCID: https://orcid.org/0000-0003-1231-1490)
- Lisa D. Burry (ORCID: https://orcid.org/0000-0002-6545-3890)
- Hannah Wunsch (ORCID: https://orcid.org/0000-0001-5477-8422)
- Nicholas A. Bosch (ORCID: https://orcid.org/0000-0001-7161-5254)
- Damon C. Scales (ORCID: https://orcid.org/0000-0001-7101-3958)
- Andrea D. Hill
Institutions
- Boston University (US)
- Mount Sinai Hospital (CA)
- St. Michael's Hospital (CA)
- Sunnybrook Health Science Centre (CA)
- University of Alberta (CA)
- University of Massachusetts Chan Medical School (US)
- University of Calgary (CA)
- University of Toronto (CA)
- Cornell University (US)
- Health Sciences Centre (CA)
- Institute for Clinical Evaluative Sciences (CA)
- UMass Memorial Medical Center (US)
- Weill Cornell Medicine (US)
Publication Details
- Journal
- Anesthesia & Analgesia
- Published
- 2025-10-29
- DOI
- https://doi.org/10.1213/ane.0000000000007821
- Citations
- 1
- Primary Topic
- Sepsis Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35